[ RECIPIENT ENTITY RECORD ]

Pfizer Seagen Platform

VERIFIED NODE ID: 002118 · pfizer-seagen-platform
R TARGET NODE — CAPITAL RECIPIENT
Pfizer Seagen Platform
SPV United States
Recipient Type
SPV
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Pfizer Seagen Platform
Entity Type SPV
Jurisdiction United States
Recipient Intelligence Summary

Pfizer Seagen Platform represents the world-class oncology organization focused on advancing antibody-drug conjugate technology for cancer patients. The project is a primary driver of innovation in targeted chemotherapy. It was the destination for one of the largest institutional healthcare acquisitions in biotech history.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $43.0B